Skip to main content

Table 5 MiRNAs commonly deregulated in CRC clinical samples and CRC cell lines.

From: Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer

miRNA fold change location CRC Fragile site*
hsa-miR-20a up 13q31.3 gain
hsa-miR-19a up 13q31.3 gain
hsa-miR-17-5p up 13q31.3 gain
hsa-miR-93 up 7q22.1 gain
hsa-miR-25 up 7q22.1 gain
hsa-miR-31 up 9p21.3  
hsa-miR-106a up Xq26.2  
hsa-miR-143 down 5q32 loss
hsa-miR-145 down 5q32 loss
hsa-miR-125a down 19q13.41 gain
hsa-miR-1 down 18q12.3 or 20q13.33 loss (18q) or gain (20q)
  1. * Summarized from [4143]